E

Eye Research Foundation | Newport Beach, CA

Research site
(Unclaimed)
Location
520 Superior Avenue, Suite 235, Newport Beach, California, United States of America
Site insights

Top conditions

Keratoconjunctivitis Sicca (26 trials)

Dry Eye Syndromes (26 trials)

Glaucoma (20 trials)

Eye Diseases (20 trials)

Open-Angle Glaucoma (20 trials)

Top treatments

Bimatoprost
Latanoprost
AR-15512
AGN-190584
AGN-195263
MT10109L
AMDX-2011P
DE-117
RVL-1201
KPI-121

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

12 of 67
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512 (COMET-4)

This will be a 12-month, multicenter, vehicle-controlled, double-masked, randomized Phase 3 study conducted at approximately 10 sites in the United S...

Active, not recruiting
Dry Eye Disease
Drug: AR-15512 Ophthalmic Solution
Drug: Vehicle
Locations recently updated

This study is a multicenter, double-masked, vehicle-controlled, randomized, parallel group study designed to evaluate the treatment of abnormal meibo...

Begins enrollment this month
Dry Eye Disease
Other: Vehicle
Drug: AZR-MD-001

A randomized, double-blind, parallel-group, two-arm, multiple dose, multicenter, clinical endpoint bioequivalence study

Not yet enrolling
Open-angle Glaucoma
Ocular Hypertension
Drug: Bimatoprost Ophthalmic Solution, 0.01%
Drug: LUMIGAN® (bimatoprost ophthalmic solution) 0.01%

The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P...

Enrolling
Cerebral Amyloid Angiopathy
Drug: AMDX-2011P

The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Op...

Enrolling
Primary Open Angle Glaucoma
Drug: AMDX-2011P

The purpose of this research study is to assess safety and tolerability of a single intravenous (given through a vein) dose of the investigational re...

Enrolling
Parkinson Disease
Amyotrophic Lateral Sclerosis
Drug: AMDX2011P

The purpose of the study is to compare the efficacy and safety of 5% tavilermide ophthalmic solution to placebo for the treatment of the signs and sy...

Active, not recruiting
Dry Eye Syndromes
Dry Eye Disease
Other: Vehicle ophthalmic solution
Drug: 5% Tavilermide ophthalmic solution

The objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in...

Enrolling
Open Angle Glaucoma
Ocular Hypertension
Drug: Latanoprost 0.005%
Drug: NCX 470 0.1%

Prospective, double-masked, randomized, multi-center, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive ef...

Active, not recruiting
Elevated Intraocular Pressure
Drug: TC-002 latanoprost ophthalmic solution, 0.005%
Drug: Latanoprost ophthalmic solution, 0.005%

To demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult...

Active, not recruiting
Dry Eye
Meibomian Gland Dysfunction
Device: TearCare System
Drug: Restasis

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

Active, not recruiting
Pterygium
Drug: RMP-A03 - Dose 1
Drug: RMP-A03 - Dose 2

The aim of this research study is to assess the safety and feasibility of lowering intraocular pressure (IOP) using an experimental study drug, JV-GL...

Active, not recruiting
Open Angle Glaucoma
Ocular Hypertension
Drug: JV-GL1
Drug: Latanoprost 0.005% Ophthalmic Solution

Trial sponsors

Allergan logo

Allergan (7 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems